Imatinib for refractory chronic graft-versus-host disease with fibrotic features
Imatinib for refractory chronic graft-versus-host disease with fibrotic features is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Imatinib for refractory chronic graft-versus-host disease with fibrotic features have?
Imatinib for refractory chronic graft-versus-host disease with fibrotic features has 233 citations in the OpenAlex counts ScholarIQ stores.
When was Imatinib for refractory chronic graft-versus-host disease with fibrotic features published?
Imatinib for refractory chronic graft-versus-host disease with fibrotic features has 2009 year in the ScholarIQ index.
What is the open-access status of Imatinib for refractory chronic graft-versus-host disease with fibrotic features?
Imatinib for refractory chronic graft-versus-host disease with fibrotic features has closed oa status in the ScholarIQ index.
What is the DOI of Imatinib for refractory chronic graft-versus-host disease with fibrotic features?
The DOI for Imatinib for refractory chronic graft-versus-host disease with fibrotic features is on the source record.
What is the PMID of Imatinib for refractory chronic graft-versus-host disease with fibrotic features?
The PMID for Imatinib for refractory chronic graft-versus-host disease with fibrotic features is on the source record.
What is the OpenAlex record for Imatinib for refractory chronic graft-versus-host disease with fibrotic features?
The OpenAlex for Imatinib for refractory chronic graft-versus-host disease with fibrotic features is on the source record.